———–|————–|——-| >99% In vivo research, clinical studies, sensitive assays Gold standard; minimal impurities 98-99% Most in vitro and in vivo research Excellent quality; minor impurities acceptable 95-98% General research, screening assays Good quality; may contain measurable impurities
Monthly Archives: September 2026
——–|————-|————-|————-| GLP-1 receptor ✓ Strong ✓ Strong ✓ Strong GIP receptor ✗ ✓ Strong ✓ Moderate Glucagon receptor ✗ ✗ ✓ Moderate Insulin secretion ✓ ✓✓ ✓✓ Appetite suppression ✓✓ ✓✓ ✓✓✓ Gastric emptying ✓✓ ✓ ✓ Energy expenditure ✗ ✗ ✓✓ Fat oxidation ✗ ✓ ✓✓ Liver fat reduction ✓ ✓✓ ✓✓✓ Efficacy and […]
—|———|—————–| Bacteriostatic water Reconstitution solvent 0.9% benzyl alcohol, sterile, preservative-containing Syringes Measuring and injecting solvent 1mL, 3mL, or 5mL depending on vial size Needles Piercing vial stopper and drawing solution 18-22 gauge for drawing, 25-31 gauge for injection Alcohol swabs Sterilizing vial stoppers and injection sites 70% isopropyl alcohol pads Sharps container Safe disposal of […]
———-|————–|———–|———-| Anti-aging serum 0.5-2% 1-2x daily 8-12 weeks Wound healing 1-3% 2x daily Until healed Post-procedure 0.5-1% 2x daily 1-2 weeks Hair growth (scalp) 1-2% 1x daily 3-6 months General skin health 0.1-0.5% 1x daily Ongoing Subcutaneous/Intramuscular Research Dosage Protocol Dosage Frequency Duration Standard systemic 5-10 mg 1-2x weekly 4-8 weeks Higher dose studies 10-20 […]
——-|——–|———–|———-| Standard anti-aging 250-500 mg 1-2x weekly 4-8 weeks Higher dose studies 500-1000 mg 1x weekly 4-6 weeks Loading phase 500 mg 2x weekly 2 weeks Maintenance 250 mg Every 2-4 weeks Ongoing Neurological research 500-750 mg 1-2x weekly 8-12 weeks Subcutaneous/Intramuscular Research Dosage Protocol Dosage Frequency Notes Standard research 100-250 mg 2-3x weekly Slower […]
——|——–|———————| Mechanism Central (brain) Peripheral (blood vessels) Target MC3/MC4 receptors PDE5 enzyme Effect Desire + arousal Arousal only Works for women Yes (studied) No Onset 30-60 minutes 30-60 minutes Duration 6-12 hours 4-6 hours PT-141 Research Applications Female Sexual Dysfunction Research The most extensively studied application: Hypoactive Sexual Desire Disorder (HSDD): FDA-approved for premenopausal women […]
—————-|——–|———–|———-| Standard loading 0.5 mg (500 mcg) Once daily 7-10 days Aggressive loading 0.75-1.0 mg Once daily 5-7 days Sensitive subjects 0.25 mg (250 mcg) Once daily 10-14 days Alternative schedule 0.5 mg Every other day 2-3 weeks Maintenance Phase Protocol Dosage Frequency Standard maintenance 0.5 mg 2-3 times per week Minimal maintenance 0.25 mg […]
———–|———-|————| Aging & longevity Strong (IGF-1 elevation) Moderate Body composition Strong (lean mass, fat loss) Moderate-Strong Sleep quality Strong (pulsatile release) Moderate Recovery & repair Strong Moderate Metabolic health Strong Moderate Bone density Moderate-Strong Moderate Cognitive function Emerging research Emerging Cardiac health Research interest Research interest Dosage Protocols for Research Disclaimer: All dosage information is […]
———–|——–|———–|———-| Loading phase 4-5 mg Twice weekly 2-3 weeks Maintenance 2-2.5 mg Once weekly 4-6 weeks Acute injury study 5 mg Every 3-4 days 2-4 weeks Chronic condition 2 mg Once weekly 8-12 weeks Total research cycle typically ranges from 4-12 weeks depending on the study design. Many researchers combine TB-500 with BPC-157 for synergistic […]
———-|————-|———–| General tissue repair 200-500 mcg Once or twice daily Tendon/ligament studies 250-500 mcg Twice daily Gastrointestinal research 200-400 mcg Once daily Local injection studies 100-250 mcg At injury site Research protocols typically run 4-8 weeks, with cycle breaks to study long-term effects. How to Reconstitute BPC-157 Proper reconstitution is essential for research accuracy: Wipe […]